A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children
This study enrolls children with myopia, or nearsightedness. The purpose of this study is to learn whether the use of SYD-101, an eye solution, slows down the progression of myopia in children.
Your child will participate in this study for about 4 years. During that time, they will receive either the investigational eyedrop
or placebo, which is an eyedrop without active ingredients. The eyedrop they are given is picked randomly, like flipping a coin. Your child will take 1 drop in each eye every night at bedtime. You and your child will also have regular visits at the study clinic. This study takes place at UBMD Ophthalmology (Ross Eye Institute)at one of their three locations in WNY (Downtown, Orchard Park, or Amherst).
Compensation is available.
To evaluate the efficacy of SYD-101 for slowing the progression of myopia in children
To evaluate the safety and tolerability of SYD-101
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
-Children ages 3-14.
-Child must be in general good health.
-Must be diagnosed with myopia (nearsightedness) in both eyes.
Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
Let us know how the study team can reach you.
If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email email@example.com and someone will assist you.